APA (7th ed.) Citation

A, H., R, D., S, O., C, W., & N, C. (2023). Systematic review of efficacy and meta-analysis of safety of ranibizumab biosimilars relative to reference ranibizumab anti-VEGF therapy for nAMD treatment. BMJ open ophthalmology, 8(1), . https://doi.org/10.1136/bmjophth-2022-001205

Chicago Style (17th ed.) Citation

A, Hatamnejad, Dadak R, Orr S, Wykoff C, and Choudhry N. "Systematic Review of Efficacy and Meta-analysis of Safety of Ranibizumab Biosimilars Relative to Reference Ranibizumab Anti-VEGF Therapy for NAMD Treatment." BMJ Open Ophthalmology 8, no. 1 (2023). https://doi.org/10.1136/bmjophth-2022-001205.

MLA (9th ed.) Citation

A, Hatamnejad, et al. "Systematic Review of Efficacy and Meta-analysis of Safety of Ranibizumab Biosimilars Relative to Reference Ranibizumab Anti-VEGF Therapy for NAMD Treatment." BMJ Open Ophthalmology, vol. 8, no. 1, 2023, https://doi.org/10.1136/bmjophth-2022-001205.